Additionally, the deployment of neutralizing antibodies to deplete IL-6 or the application of the specific inhibitor AG490 to impede the JAK/STAT3 pathway significantly mitigates these CAF-induced phenotypic traits in gastric cancer cells and curtails their metastatic propensity [118]. The gene discussed is STAT3; the disease is gastric cancer.